Medpace CFO sells 3,400 shares at $625.24 each
Medpace Holdings, Inc. (MEDP) reported an insider equity transaction by Kevin M. Brady, its CFO & Treasurer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medpace Holdings, Inc. (MEDP) reported an insider equity transaction by Kevin M. Brady, its CFO & Treasurer. On August 20, 2026, he exercised employee stock options to acquire 3,400 shares of Common Stock at $138.87 per share and then sold 3,400 Common shares at $625.24 per share pursuant to a limit order placed during an open window period. Following the option exercise, he held 3,403 employee stock options of the same grant, which had vested in full on February 15, 2026 and carry an expiration date of August 15, 2027.
Insider Trade Summary
Exercise and Sale: 3,400 shares ($1.65M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Brady Kevin M.
Role
CFO & Treasurer
Sold
3,400 shs ($2.13M)
Approx. gross sale proceeds
$2.13M
Approx. exercise cost
$472K
Approx. pre-tax spread
$1.65M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F2 | 3,400 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,400 | $138.87 | $472K |
| Sale | Common Stock F1 | 3,400 | $625.24 | $2.13M |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 3,403 contracts (Direct);
Common Stock — 12,830 shares (Direct)
Footnotes (2)
- F1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- F2. The option vested in full on February 15, 2026.
Key Figures
Common shares sold: 3,400 shares
Sale price per share: $625.24 per share
Option exercise price: $138.87 per share
+5 more
8 metrics
Common shares sold
3,400 shares
Common Stock sale on 2026-08-20
Sale price per share
$625.24 per share
Sale of 3,400 Common shares on 2026-08-20
Option exercise price
$138.87 per share
Exercise of 3,400 Employee Stock Options on 2026-08-20
Options exercised
3,400 options
Employee Stock Option (Right to Buy) converted into Common Stock
Options remaining after transaction
3,403 options
Employee Stock Option holdings following the exercise
Option vesting date
February 15, 2026
Footnote states the option vested in full on this date
Option expiration date
August 15, 2027
Expiration date of the Employee Stock Option
Transaction date
August 20, 2026
Date of option exercise and share sale
Key Terms
Employee Stock Option (Right to Buy), limit order, open window period, derivative security, +1 more
5 terms
Employee Stock Option (Right to Buy) financial
"security_title: "Employee Stock Option (Right to Buy)""
limit order financial
"effected pursuant to a limit order placed by the Reporting Person"
A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.
open window period regulatory
"limit order placed by the Reporting Person during an open window period"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Rule 10b5-1 regulatory
"Rule 10b5-1 checkbox is present at the document level"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MEDP CFO Kevin M. Brady report on this Form 4?
Kevin M. Brady reported exercising 3,400 employee stock options for Medpace Holdings, Inc. (MEDP) Common Stock at an exercise price of $138.87 per share and selling 3,400 Common shares at $625.24 per share on August 20, 2026.
How many Medpace (MEDP) options does Kevin M. Brady hold after this transaction?
After the reported transactions, Kevin M. Brady held 3,403 employee stock options for Medpace Holdings, Inc. (MEDP), as reported in the Form 4 for the option security titled “Employee Stock Option (Right to Buy).”
When did the MEDP options vest and when do they expire?
The employee stock option used in this transaction vested in full on February 15, 2026 and has an expiration date of August 15, 2027, as disclosed in the Form 4 footnotes.
Was the MEDP insider sale executed under a Rule 10b5-1 trading plan?
The Rule 10b5-1 checkbox was not affirmed. A footnote states the transactions were carried out under a limit order placed during an open window period, but it does not describe them as pursuant to a Rule 10b5-1 trading plan.
What type of transaction code was used for the MEDP insider sale?
The sale of Medpace (MEDP) Common Stock used transaction code S, indicating a sale in an open market or private transaction. The related option transaction used code M for the exercise or conversion of a derivative security.
AI-generated analysis. How Rhea-AI works. Not financial advice.
